Laddar...
Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus
BACKGROUND: Sitagliptin is a highly selective dipeptidyl peptide-4 (DPP-4) inhibitor that increases blood levels of active glucagon-like peptide (GLP)-1 and glucose-dependent insulinotrophic polypeptide (GIP), resulting in increased insulin secretion. While studies conducted in other countries have...
Sparad:
| Huvudupphovsmän: | , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Korean Diabetes Association
2011
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3122893/ https://ncbi.nlm.nih.gov/pubmed/21738898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2011.35.2.159 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|